Literature DB >> 24077131

Update on the neurobiology of schizophrenia: a role for extracellular microdomains.

D Shan1, S Yates, R C Roberts, R E McCullumsmith.   

Abstract

The glutamate system includes presynaptic glutamatergic terminals, complex post-synaptic densities found on diverse types of neurons expressing glutamate receptors, as well as glutamate transporters and enzymes that facilitate the glutamate/glutamine cycle. Abnormalities of this system have been implicated in schizophrenia based on an accumulating body of evidence from postmortem, imaging, and preclinical studies. However, recent work has suggested that astrocytes may have more than a bystander role in the synchronization of neuronal responses in the brain. Converging evidence suggests that extrasynaptic glutamate microdomains are formed by astrocytes and may facilitate neuroplasticity via the modulation of extra-synaptic glutamate receptors on neuronal membranes within these domains. In this article the authors propose that the composition and localization of protein complexes in glutamate microdomains is abnormal in schizophrenia, leading to pathological neuroplastic changes in the structure and function of glutamate circuits in this illness.

Entities:  

Keywords:  Glutamate; Microdomain; Protein complex; Schizophrenia

Year:  2012        PMID: 24077131      PMCID: PMC3783347     

Source DB:  PubMed          Journal:  Minerva Psichiatr        ISSN: 0374-9320


  172 in total

1.  Glutamate spillover promotes the generation of NMDA spikes.

Authors:  Jason R Chalifoux; Adam G Carter
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Glutamate transporters bring competition to the synapse.

Authors:  Yanhua H Huang; Dwight E Bergles
Journal:  Curr Opin Neurobiol       Date:  2004-06       Impact factor: 6.627

3.  Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.

Authors:  L V Kristiansen; B Bakir; V Haroutunian; J H Meador-Woodruff
Journal:  Schizophr Res       Date:  2010-03-29       Impact factor: 4.939

4.  Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia.

Authors:  Dan Shan; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Neuroreport       Date:  2012-03-07       Impact factor: 1.837

Review 5.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

6.  Block of glutamate transporters potentiates postsynaptic excitation.

Authors:  G Tong; C E Jahr
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

7.  Flux coupling in a neuronal glutamate transporter.

Authors:  N Zerangue; M P Kavanaugh
Journal:  Nature       Date:  1996-10-17       Impact factor: 49.962

8.  Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.

Authors:  Martin R Gluck; Rohan G Thomas; Kenneth L Davis; Vahram Haroutunian
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

9.  Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.

Authors:  Nathan L Hutcheson; Meredith A Reid; David M White; Nina V Kraguljac; Kathy B Avsar; Mark S Bolding; Robert C Knowlton; Jan A den Hollander; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2012-07-23       Impact factor: 4.939

10.  Extrasynaptic NR2D-containing NMDARs are recruited to the synapse during LTP of NMDAR-EPSCs.

Authors:  Sarah C Harney; David E Jane; Roger Anwyl
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

View more
  14 in total

Review 1.  Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction.

Authors:  Robert E McCullumsmith; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2015-01       Impact factor: 7.853

2.  Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.

Authors:  R C Roberts; J K Roche; R E McCullumsmith
Journal:  Neuroscience       Date:  2014-07-24       Impact factor: 3.590

3.  Altered serine/threonine kinase activity in schizophrenia.

Authors:  Jennifer L McGuire; John H Hammond; Stefani D Yates; Dongquan Chen; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Brain Res       Date:  2014-04-26       Impact factor: 3.252

4.  Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.

Authors:  Danielle L Taylor; Arun K Tiwari; Jeffrey A Lieberman; Steven G Potkin; Herbert Y Meltzer; Joanne Knight; Gary Remington; Daniel J Müller; James L Kennedy
Journal:  Mol Neuropsychiatry       Date:  2016-10-12

5.  Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.

Authors:  Marco Matos; Hai-Ying Shen; Elisabete Augusto; Yumei Wang; Catherine J Wei; Yu Tian Wang; Paula Agostinho; Detlev Boison; Rodrigo A Cunha; Jiang-Fan Chen
Journal:  Biol Psychiatry       Date:  2015-02-27       Impact factor: 13.382

Review 6.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

Review 7.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

8.  Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?

Authors:  R E McCullumsmith; S M O'Donovan; J B Drummond; F S Benesh; M Simmons; R Roberts; T Lauriat; V Haroutunian; J H Meador-Woodruff
Journal:  Mol Psychiatry       Date:  2015-09-29       Impact factor: 15.992

9.  Cell-subtype-specific changes in adenosine pathways in schizophrenia.

Authors:  Sinead Marie O'Donovan; Courtney Sullivan; Rachael Koene; Emily Devine; Kathryn Hasselfeld; Cassidy Lynn Moody; Robert Erne McCullumsmith
Journal:  Neuropsychopharmacology       Date:  2018-02-26       Impact factor: 7.853

10.  Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala.

Authors:  H Pantazopoulos; M Markota; F Jaquet; D Ghosh; A Wallin; A Santos; B Caterson; S Berretta
Journal:  Transl Psychiatry       Date:  2015-01-20       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.